How does First Solar make money?

FIRST SOLAR, INC. – Business Breakdown

The Essentials

First Solar, Inc. is a vertically oriented photovoltaic manufacturer focused on cadmium telluride (CdTe) thin-film solar modules, produced through a proprietary vapor transport deposition process. The company’s industrial footprint is meaningfully diversified across the United States, Malaysia, and Vietnam, with a sixth U.S. facility under construction and scheduled to begin operations in H2 2026. That footprint is strategically important: it supports domestic manufacturing scale, positions the company to benefit from U.S. policy incentives, and reduces reliance on Chinese supply chains. In 2025, the company produced 16.1 GW and sold 17.5 GW of modules, underscoring a business model anchored in high-volume module output rather than segment diversification.

Business Model & Revenue Drivers

First Solar’s economic engine is concentrated in module manufacturing and sales, with no segment revenue breakdown disclosed in the filings. Based on the source data, the principal value drivers are:

• PV solar module sales
  The core revenue source is the sale of CdTe thin-film photovoltaic modules. In 2025, the company produced 16.1 GW and sold 17.5 GW, indicating strong throughput and commercial demand.

• U.S. manufacturing and Section 45X tax credits
  Domestic manufacturing is a material economic lever. The filings reference $701.9 million of Section 45X tax credits sold in 2025, with an additional $391 million agreement referenced in July 2025. This suggests policy-linked monetization is an important contributor to cash generation and margin support.

• International module sales
  The company sells modules globally, with manufacturing and operational exposure in Malaysia and Vietnam. The filings also reference demand/supply imbalances in Europe and India, implying that international market conditions remain relevant to revenue realization.

• Capacity expansion and manufacturing ramp
  The Louisiana ramp and the sixth U.S. facility under construction are not revenue lines themselves, but they are central to future volume growth and the company’s ability to scale output while maintaining a differentiated cost structure.

Strategic Edge & Market Positioning

First Solar’s positioning is best understood as a combination of technological differentiation and operational execution, but the filings do not support the conclusion that it possesses a durable economic moat in the classic sense.

Economic Moat

• Limited evidence of structural moat
  The source explicitly states that no sustainable economic moat has been identified.
• Technology differentiation, but not clear defensibility
  CdTe thin-film technology uses only 2–3% of semiconductor material versus crystalline silicon and is tuned to the solar spectrum for performance in certain climates. The company also has two world-record research cell efficiencies certified by NREL. However, these attributes are presented as technical advantages rather than barriers that are clearly difficult to replicate.
• Patent portfolio under pressure
  The ‘074 patent is subject to reexaminations and litigation, which weakens the case for a durable intellectual-property moat.

Execution Advantage

• Manufacturing scale and process discipline
  The company has sold 93 GW cumulatively and operates a large manufacturing base across multiple geographies. This scale supports procurement, throughput, and operational learning.
• U.S.-based footprint
  Domestic manufacturing helps the company avoid Chinese supply-chain exposure and aligns it with policy incentives, but this is framed in the source as an execution advantage rather than a structural barrier.
• Cost reduction initiatives
  The CuRe program and Series 7 modules are described as operational improvements aimed at lowering cost per watt and improving module performance. These initiatives may enhance competitiveness, but the filings indicate they are replicable rather than moat-creating.
• Competitive environment remains harsh
  The industry is characterized by Chinese crystalline silicon overcapacity, pricing near or below cost, and structural supply-demand imbalances. That backdrop limits pricing power and underscores the absence of a clearly entrenched moat.

Outlook & Innovation Pipeline

Over the next three years, the company’s strategic trajectory appears centered on capacity expansion, cost reduction, and incremental technology deployment rather than a wholesale business-model shift.

• U.S. manufacturing expansion
  The Louisiana Series 7 ramp and the sixth U.S. facility, expected to begin operations in H2 2026, are the most visible near-term growth catalysts. These investments appear designed to expand domestic capacity and support onshoring of international module finishing.

• Technology rollout and process optimization
  The CuRe program is a key cost-reduction initiative, while Series 7 modules represent the next stage of product and manufacturing evolution. The filings suggest ongoing R&D deployment from Ohio to global lines, indicating a focus on transferring process improvements across the manufacturing base.

• Policy-linked growth support
  Section 45X credits remain strategically important to the company’s economics, and the filings imply that continued U.S. manufacturing expansion is closely tied to capturing these incentives.

• Innovation remains applied, not speculative
  The source references research cell efficiency records and proprietary deposition technology, but these are described as lab-level achievements and process capabilities rather than evidence of a near-term disruptive product cycle. The practical emphasis is on wattage improvements, cost/watt reduction, and scalable manufacturing execution.